Written by Dr. Richard Soltero, President, InstantGMP

Every vendor selling AI for pharmaceutical quality wants you to believe the model is the hard part. Buy the algorithm, point it at your batch records, and it will flag the next deviation before it happens. I have spent more than thirty years building quality systems and laboratory software for regulated manufacturers, and the model is almost never where these projects fail. They fail on the data.

Predictive quality is a real opportunity for pharma. Instead of discovering an out-of-specification result after a batch has already failed, you use the history sitting in your batch records, deviations, and stability data to see the conditions that come before failure. The promise is prevention instead of reaction. But that promise rests entirely on the quality of the records that are used for this analysis.

Why Clean Data Decides Everything

Where does pharmaceutical quality data actually live? In a typical plant, a lot of it is in a validated system. But even now, a surprising amount sits in spreadsheets, email threads, a logbook on the QC bench, and someone’s memory of how the granulation behaved last campaign. While electronic batch records have been around for decades, it is amazing how many companies still use spreadsheets. I see it over and over.

If you ask an AI to predict an out-of-specification result from that, I am confident you will get the wrong answer. It cannot reconcile a value logged one way on the day shift and another on nights. It cannot weigh a free-text note that says “looked a little off.” It cannot trust a timestamp filled in from memory after the fact. The model does not know the data is bad. It learns the noise and hands it back with a confidence score, which is worse than no answer at all, because now the wrong answer looks authoritative.

What the 483 Observations Already Tell You

The patterns are not new. Year after year, FDA Form 483 observations and warning letters cite the same root issues: incomplete batch records, data integrity gaps, deviations that were never trended, and investigations that did not connect to prior events. A predictive AI does not fix any of that. AI depends on the records and if those observations are missing or unreliable, AI can’t help. If your data has a hole in it, the model will faithfully predict everything except the failure that falls through that hole.

So can AI predict an out-of-specification result before a batch fails? Yes, but only if your in-process results, environmental monitoring, and equipment data were captured consistently and at the source under 21 CFR Part 211, and tied together so a model can see across batches. The prediction is downstream of the data discipline. It always is.

What Most Manufacturers Get Wrong

The mistake I see most often is buying the AI before fixing the records. It is the more appealing order of operations, because the model is the exciting part and data cleanup is the chore nobody wants to do.

Building a predictive system on messy batch records is like forecasting a stability trend from assays run on instruments that were never validated. You can apply the most sophisticated model on earth and still be guessing.

Most quality problems that occurred in my 30-plus year career started with a single issue that exposed a gap in the quality system. Predictive AI inherits those gaps. It does not close them.

Where Good Data Actually Comes From

Clean data is not something you reconstruct after the fact. It comes from capturing the right information, in a controlled structure, at the moment the work happens. That means using electronic batch records where the fields are defined and enforced instead of free text. It means using  a LIMS where every result carries its units, method, and timestamp automatically. And it means a quality system where every entry has an audit trail and an electronic signature, the traceability that 21 CFR Part 11 has required of regulated records for years and 21 CFR Part 211 expects of finished pharmaceutical production.

This is the unglamorous foundation that makes prediction possible later. It is also just good manufacturing. We have adapted AI as a tool to improve our electronic software solutions and to improve our quality management systems, and the first thing that work taught us is that the AI is the last mile, not the first.

How InstantGMP Fits

InstantGMP is a global manufacturing platform built on this principle. The electronic batch records, inventory management, LIMS, and the iQMS.ai quality management system are designed to capture structured, traceable data first for pharmaceutical and biotech manufacturers, and across dietary supplement, medical device, food and beverage, and contract manufacturing operations as well. Clean and connected from the start, that data is ready to support prediction and continuous improvement, not just survive an inspection.

What This Means for Pharma Quality Teams

If you are evaluating predictive quality tools this year, flip the order. Do not start with the model. Start with the records. Ask where your data is, what shape it is in, and whether a machine could trust it without a validation specialist translating first.

Get that right and prediction becomes a natural extension of cGMP record-keeping. Get it wrong and the smartest model on the market will only help you reach the wrong conclusion faster, with a confidence score attached. In a regulated plant, the future of predictive quality belongs to the manufacturers who did the boring work first.